All News #Library
Biotech
EvolveImmune Hits Preclinical Milestone with AbbVie
28 Apr 2026 //
GLOBENEWSWIRE
EvolveImmune to Present EVOLVE104, EVOLVE Data at 2026 Conference
14 Apr 2026 //
GLOBENEWSWIRE
Evolveimmune Initiates Phase 1 Trial Of EVOLVE104 In Solid Tumors
16 Dec 2025 //
GLOBENEWSWIRE
EvolveImmune`s EVOLVE104 Trispecific T Cell Engager FDA Cleared
14 Aug 2025 //
GLOBENEWSWIRE
EvolveImmune Therapeutics Collaborates on Tumor Target Study
08 Apr 2025 //
GLOBENEWSWIRE
EvolveImmune Appoints Kristen M. Hege to Its Board of Directors
11 Feb 2025 //
GLOBENEWSWIRE
EvolveImmune Presents Preclinical Data on EVOLVE T Cell Engager
11 Nov 2024 //
GLOBENEWSWIRE
AbbVie & EvolveImmune Announce Cancer Biotherapeutics Collaboration
31 Oct 2024 //
GLOBENEWSWIRE
Immunotherapy biotech raises $37M from backers like Pfizer, Takeda, BMS
13 Dec 2023 //
ENDPTS

Market Place
Sourcing Support